Targeted drugs aimed at driver gene, such as Gefitinib, Erlotinib and Crizotinib, have an irreplaceable position in the therapy of advanced non-small cell lung cancer. These drugs bring benefit to patients, however, higher hepatotoxicity is also presented. Now, drug induced hepatotoxicity and its mechanism are reviewed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000506 | PMC |
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.09.08 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!